Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood aspartate transaminase amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000581,serum aspartate aminotransferase activity level,,,,61.8,U/l,1.3193,2.95,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105049,control condition (for 63 days) 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood alanine transaminase amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000575,serum alanine aminotransferase activity level,,,,54.8,U/l,0.9705,2.17,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105051,control condition (for 63 days) 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood alkaline phosphatase amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000577,serum alkaline phosphatase activity level,,,,294.2,U/l,28.4204,63.55,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105053,control condition (for 63 days) 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood bilirubin amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000376,serum total bilirubin level,,below lower limit,,0.1,mg/dl,0.0,0.0,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105055,control condition (for 63 days) 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood urea nitrogen amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000587,serum urea nitrogen level,,,,12.4,mg/dl,0.246,0.55,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105059,control condition (for 63 days) 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood creatinine amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000057,serum creatinine level,,,,0.23,mg/dl,0.0045,0.01,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105061,control condition (for 63 days) 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood cholesterol amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000363,serum total cholesterol level,,,,89.4,mg/dl,3.3273,7.44,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105063,control condition (for 63 days) 3010,"Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011.",blood glucose amount,,RS:0000695,Crl:SD,male,63 days,5,,CMO:0000543,serum glucose level,,,,132.6,mg/dl,2.5223,5.64,MMO:0000554,automated serum analysis,,0.0,,,,,control condition (for 63 days),105065,control condition (for 63 days)